Feasibility and Safety of Tailored Lymphadenectomy Using Sentinel Node-Navigated Surgery in Patients with High-Risk T1 Esophageal Adenocarcinoma.

"Disclosure C.N. Frederiks has received speaker’s fee from Pentax Medical. J.J.G.H.M. Bergman is a consultant for Boston Scientific, Cook Medical and Medtronic, and has received research funding from Aqua Medical, Fuji Film, Olympus Endoscopy, Pentax Medical and Medtronic. R. van Hillegersberg is a consultant for Intuitive Surgical and Medtronic. J.P. Ruurda is a consultant for Intuitive Surgical. M.I. van Berge Henegouwen is a consultant for Alesi Surgical, BBraun, Johnson & Johnson, Medtronic and Viatris, and has received research funding from Stryker. B.L.A.M. Weusten is a consultant for Pentax Medical, has received speaker’s fee from Pentax Medical, and has received research funding from Aqua Medical and Pentax Medical. The remaining authors have no disclosures to declare relevant to this manuscript."

"Funding This study was financially supported by the Dutch Cancer Society (KWF Kankerbestrijding, Project Number 10944)."

"The study protocol and subsequent amendments were reviewed and approved by the Medical Research Ethics Committees United. Written informed consent was obtained from all study participants. A Data Safety Monitoring Board was established to monitor patient safety. This study was registered in the Netherlands Trial Register (NL8100)."